Over the last few months, I’ve written a few posts about SB-519, a bill introduced by California State Senator Scott Wiener earlier this year that is intended to decriminalize a host of psychedelics – from psilocybin to ketamine to LSD (you can read those posts here, here, and here). SB-519 has passed through the California
Our posts here regularly cover celebrity-backed cannabis companies who are doing things right (and sometimes, doing things wrong), but a recent copyright infringement case proves that not all celebrities are interested in getting involved in the industry – and certainly shouldn’t be presumed to be okay with using their fame to promote it. Solar Therapeutics
We’ve been writing about psychedelics on this blog now for three years. I believe the first article I wrote covered Food and Drug Administration (FDA) approval of Compass Pathway’s drug trial for COMP360, a psilocybin formulation that eventually was patented. Since that time, a LOT has happened in the space, and we have seen all
On Wednesday, a draft bill was released to end America’s federal cannabis prohibition and remove “marijuana” from the Controlled Substances Act. The bill, sponsored by Senate Majority Leader Chuck Schumer (D-NY), Sen. Ron Wyden (D-OR), and Sen. Cory Booker (D-NJ) is titled the Cannabis Administration and Opportunity Act and was introduced as a discussion draft
This week, Governor Newsom took a major step in reforming California’s (pretty tortured) cannabis licensing program by signing into law Assembly Bill 141, which generally consolidates all cannabis licensing and oversight into the Department of Cannabis Control (“DCC”). In our view, centralizing all licensing and regulatory oversight into a single agency in California is a
On June 28, US sprinter Sha’Carri Richardson was suspended for one month by the World Anti-Doping Agency (WADA) for using cannabis, effectively disqualifying her from competing in the Olympics. The suspension of a gold medal contending athlete caught many by surprise and sparked a worldwide debate about marijuana use by athletes should be addressed. Many
REGISTER TODAY! In March of 2021 New York became the 15th State to legalize recreational cannabis through the passage of the Marijuana Regulation and Taxation Act. New York City is poised to become the retail epicenter of New York’s cannabis industry with the potential influx of several types of cannabis business, most notably retail dispensaries
Listen to the blog post here: https://harrisbricken.com/wp-content/uploads/New-York-Cannabis-The-Town-of-Riverhead-Voted-Not-to-Opt-Out-Its-a-Big-Deal.mp3 As we continue to wait for Governor Andrew Cuomo to nominate a Chairperson for the Cannabis Control Board (CCB), effectively kickstarting the rule making process, a surprising and welcome piece of news came down. On July 7, 2021, the Town of Riverhead voted not to opt out
Listen to the blog post here: Over the last few years, I’ve been asked to review dozens and dozens of mockup cannabis labeling material to see whether they comply with California’s complex cannabis labeling requirements. I can’t recall a single instance in which I didn’t catch at least a few problems that needed changing.
While the Food and Drug Administration (the FDA) continues to drag its feet in forging a legal path for the manufacture, sale, and distribution of hemp-derived products, state regulators are keeping up with the demands of this evolving market and adopting increasingly more nuanced and more sophisticated regulations for these products. Several states, including Oregon
